Siena Napoleon

Siena Napoleon

Auto-generated profile, based on publicly available information

Siena Napoleon

Brown University School of Public Health, Providence, RI, USA; Center for Health Promotion and Health Equity, Brown School of Public Health, Providence, RI, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in International Journal of Drug Policy
Verified
Journal Article
Closed access
WLWilliam Lodge
William Lodge
PKPatrick JA Kelly
Patrick JA Kelly
SNSiena Napoleon
Siena Napoleon
SPSamantha Plezia
Samantha Plezia
MMMatthew J. Mimiaga
Matthew J. Mimiaga
KBKatie B. Biello
Katie B. Biello

10 February 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
MMMatthew Murphy
Matthew Murphy
CSCollette Sosnowy
Collette Sosnowy
BRBrooke Rogers
Brooke Rogers
SNSiena Napoleon
Siena Napoleon
DGDrew Galipeau
Drew Galipeau
PCPhilip A Chan
Philip A Chan
Background: HIV disproportionately impacts criminal justice–involved individuals, including men who experience incarceration. Men make up the vast majority of those experiencing incarceration as well as those newly diagnosed with HIV infection. Pre-exposure prophylaxis (PrEP) is a highly effective biomedical intervention that significantly reduces the risk of HIV acquisition. However, implementation in criminal justice systems is limited. Little is known about effective PrEP implementation and use in this unique public health context. Objective: The aim of this study is to characterize the experience of implementing PrEP clinical care in a criminal justice setting for men vulnerable to HIV acquisition. Methods: This article describes a PrEP care continuum for men experiencing incarceration who are at increased risk of HIV acquisition, which can help conceptualize approaches to evaluating PrEP implementation. Results: The outlined study will enroll 100 men experiencing incarceration at high risk for HIV acquisition prior to release into the community. The goal is to initiate PrEP prior to release and link individuals to PrEP providers in the community, capturing barriers and facilitators to PrEP use during this uniquely vulnerable time period for HIV acquisition. Conclusions: Based on the proposed care continuum and what is known about HIV risk and prevention efforts in the criminal justice context, we outline key future research efforts to better understand effective approaches to preventing HIV infection among this vulnerable population. The described approach presents a powerful public health opportunity to help end the HIV epidemic. International Registered Report Identifier (IRRID): DERR1-10.2196/31928

27 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SNSiena Napoleon
Siena Napoleon
MSMalabika Sarker
Malabika Sarker
GWGalya Walt
Galya Walt
JRJack Rusley
Jack Rusley
KAKaren Andes
Karen Andes
KBKatie B. Biello
Katie B. Biello
BackgroundAdolescents and young adults (AYA) with opioid use disorder (OUD) remain less likely than adults to receive medications for opioid use disorder (MOUD), despite clinical guidance supporting pharmacotherapy and evidence that early medication treatment improves engagement. Primary care may offer a developmentally appropriate setting for AYA MOUD delivery; however, limited evidence describes the workflows required to support movement from first contact to medication initiation and follow-up.MethodsWe conducted a multi-site qualitative implementation study with clinicians and staff involved in AYA MOUD delivery across four primary care-based programs in Greater Boston. Between July and November 2025, the first author conducted semi-structured Zoom interviews with 12 participants: physicians (n = 6), nurse practitioners (n = 3), one registered nurse/care manager, one patient navigator, and one administrator. Interviews examined referral pathways, treatment initiation, medication access, staffing, behavioral health linkage, and perceived barriers and facilitators. CFIR informed development of the interview guide and initial code structure. Codes were applied with attention to site-specific workflows and implementation practices, followed by hybrid deductive-inductive thematic analysis to identify pathway-centered themes.ResultsParticipants described AYA MOUD delivery as a sequence of time-sensitive operational steps--including outreach, scheduling, confidentiality communication, prescription routing, pharmacy coordination, fill confirmation, and early follow-up--rather than a discrete prescribing event. Four themes characterized how clinics supported initiation and early engagement for a population with unique developmental needs. First, rapid, low-barrier entry supported conversion of referrals into treatment initiation through same- or next-day outreach, flexible first-touch options, and clear confidentiality communication. Second, compact interdisciplinary teams sustained engagement by assigning ownership for outreach, missed visits, refills, family communication, and follow-up. Third, medication access depended on infrastructure that fit routine clinic work, including prior authorization ownership, pharmacy communication, order sets, and tracking prescription completion. Fourth, harm reduction services and behavioral health bridge care supported continuity during instability or delayed specialty care access. Across sites, implementation varied in staffing, co-location, electronic health record capacity, and pharmacy partnerships, and participants emphasized visible task ownership and reliable handoffs.ConclusionsAYA MOUD implementation in primary care requires more than prescriber availability. Clinics must organize treatment as coordinated, developmentally responsive, and measurable work, with explicit ownership for rapid entry, medication access, early follow-up, and bridge support. Findings identify implementation targets for future evaluation, including time to first contact, time to first dose, medication fill completion, early follow-up, and retention in care.

12 July 2021 in JMIR Preprints
Verified
Preprint
Open access
MMMatthew Murphy
Matthew Murphy
CSCollette Sosnowy
Collette Sosnowy
BRBrooke Rogers
Brooke Rogers
SNSiena Napoleon
Siena Napoleon
DGDrew Galipeau
Drew Galipeau
PCPhilip A Chan
Philip A Chan
BACKGROUND HIV disproportionately impacts criminal justice–involved individuals, including men who experience incarceration. Men make up the vast majority of those experiencing incarceration as well as those newly diagnosed with HIV infection. Pre-exposure prophylaxis (PrEP) is a highly effective biomedical intervention that significantly reduces the risk of HIV acquisition. However, implementation in criminal justice systems is limited. Little is known about effective PrEP implementation and use in this unique public health context. OBJECTIVE The aim of this study is to characterize the experience of implementing PrEP clinical care in a criminal justice setting for men vulnerable to HIV acquisition. METHODS This article describes a PrEP care continuum for men experiencing incarceration who are at increased risk of HIV acquisition, which can help conceptualize approaches to evaluating PrEP implementation. RESULTS The outlined study will enroll 100 men experiencing incarceration at high risk for HIV acquisition prior to release into the community. The goal is to initiate PrEP prior to release and link individuals to PrEP providers in the community, capturing barriers and facilitators to PrEP use during this uniquely vulnerable time period for HIV acquisition. CONCLUSIONS Based on the proposed care continuum and what is known about HIV risk and prevention efforts in the criminal justice context, we outline key future research efforts to better understand effective approaches to preventing HIV infection among this vulnerable population. The described approach presents a powerful public health opportunity to help end the HIV epidemic. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/31928